Worth reading
38Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
18
Millions of yenWording
Conditional
How definitive the wording is.Contents of this document
Supplementary Materials to the Earnings SummarySecond quarter (interim period) of the fiscal year ending March 20277 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales2,105 Millions of yen+0.9%
Operating profit-398 Millions of yen
Ordinary income-450 Millions of yen
Net income-451 Millions of yen
Gross Profit Margin
Rate25.6
Year-on-year change (points)-2
Full-year earnings forecast
Net Sales
60 Hundreds of millions of yen
Operating profit
4 Hundreds of millions of yen
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Revenue from Municipal National Health Insurance
Change in amount178 Millions of yen
Revenue from Other Customers
Change in amount-26 Millions of yen
Revenue from Data Health-Related Services
Change in amount152 Millions of yen
Revenue from Data Utilization Services
Change in amount-121 Millions of yen
Other revenue
Change in amount-13 Millions of yen
Gross profit
Change in amount-36 Millions of yen
Operating profit
Change in amount-6 Millions of yen
Ordinary income
Change in amount-58 Millions of yen
New initiatives
- Rollout of AI products combining proprietary data with AI
- Joint PoC with partners in the Global South
- Expansion into adjacent areas, including nursing care and frailty prevention
- Joint development of real-world data (RWD) and AI
- Improving productivity in existing operations through the use of AI
Key KPIsA metric the company considers important as a management benchmark.
- Number of companies using data utilization services84 companiesYear on year against the same period last year+20%
- Number of companies using data utilization services (same period of previous year)70 companies
- Number of orders received for data health-related services from municipalities covered by National Health Insurance447 Deals
- Number of orders received for data health-related services from other customers147 Deals
- Number of companies conducting transactions (including pharmaceutical companies, etc.)36 companies
- Proprietary health big dataMore than 19 million people
- Number of municipalities servedApproximately 700
Unit price and quantity metricsThese figures show sales broken down by price and volume.
Number of customers
84 companies+20.0%
Transaction value per customer among the top 20 customers
Year on year against the same period last year-1.5%
Segment results
Data health-related services
Net Sales
1,763 Millions of yen
Year-on-year change
152 Millions of yen
Data utilization services
Net Sales
309 Millions of yen
Year-on-year change
-121 Millions of yen
Other
Net Sales
33 Millions of yen
Year-on-year change
-13 Millions of yen
Medium-term management plan targets
Operating profit margin
15% or higher
Target fiscal yearFY2030
AI-related revenue ratio
20% or higher
Target fiscal yearFY2030
Market capitalization
¥10 billion
Target fiscal yearEarly achievement
Financial targets
Operating profit margin
Target value15% or higher
Target fiscal yearFY2030
| Item | Details |
|---|---|
| Document type | Supplementary Materials to the Earnings Summary |
| Fiscal Period Covered | Second quarter (interim period) of the fiscal year ending March 2027 |
| Net Sales | 2,105 Millions of yen (YoY +0.9%) |
| Operating profit | -398 Millions of yen |
| Ordinary income | -450 Millions of yen |
| Net income | -451 Millions of yen |
| Gross Profit Margin | Rate 25.6 / Year-on-year change (points) -2 |
| Full-year earnings forecast | Net Sales 60 Hundreds of millions of yen / Operating profit 4 Hundreds of millions of yen |
| Segment results | Data health-related services Net Sales 1,763 Millions of yen / Year-on-year change 152 Millions of yen / Profit Not disclosed / Data utilization services Net Sales 309 Millions of yen / Year-on-year change -121 Millions of yen / Profit Not disclosed / Other Net Sales 33 Millions of yen / Year-on-year change -13 Millions of yen / Profit Not disclosed |
| Breakdown of Factors Affecting the Change | Revenue from Municipal National Health Insurance Change in amount 178 Millions of yen / Revenue from Other Customers Change in amount -26 Millions of yen / Revenue from Data Health-Related Services Change in amount 152 Millions of yen / Revenue from Data Utilization Services Change in amount -121 Millions of yen / Other revenue Change in amount -13 Millions of yen / Gross profit Change in amount -36 Millions of yen / Operating profit Change in amount -6 Millions of yen / Ordinary income Change in amount -58 Millions of yen |
| Key KPIs | Indicator name Number of companies using data utilization services / Value 84 companies / Year on year against the same period last year +20%, Indicator name Number of companies using data utilization services (same period of previous year) / Value 70 companies / Year on year against the same period last year Not disclosed, Indicator name Number of orders received for data health-related services from municipalities covered by National Health Insurance / Value 447 Deals / Year on year against the same period last year Not disclosed, Indicator name Number of orders received for data health-related services from other customers / Value 147 Deals / Year on year against the same period last year Not disclosed, Indicator name Number of companies conducting transactions (including pharmaceutical companies, etc.) / Value 36 companies / Year on year against the same period last year Not disclosed, Indicator name Proprietary health big data / Value More than 19 million people / Year on year against the same period last year Not disclosed, Indicator name Number of municipalities served / Value Approximately 700 / Year on year against the same period last year Not disclosed |
| Unit price and quantity metrics | Number of customers 84 companies (YoY +20.0%) / Transaction value per customer among the top 20 customers value Not disclosed / yoy_pct -1.5 Down 1.5% year on year |
| Medium-term management plan targets | Operating profit margin 15% or higher / AI-related revenue ratio 20% or higher / Market capitalization ¥10 billion |
| Financial targets | Operating profit margin Target value 15% or higher / Target fiscal year FY2030 |
| New initiatives | Rollout of AI products combining proprietary data with AI, Joint PoC with partners in the Global South, Expansion into adjacent areas, including nursing care and frailty prevention, Joint development of real-world data (RWD) and AI, Improving productivity in existing operations through the use of AI |
Items this document does not state (16)
Operating profit marginSelling, general and administrative expensesResults for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Data health-related services increased against the backdrop of demand for support in preparing interim evaluations of data health plans. Data utilization services declined due to the reaction to a large project recorded in the same period of the previous year. The operating loss was attributed to seasonality, as well as increases in salaries and depreciation expenses.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.